Alan Siroy
Impact in
- Dermatology top 5%
-
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in ⓘ
- Oncology 11
- Cutaneous Melanoma Detection and Management 7
- HER2/EGFR in Cancer Research 3
- Cancer Diagnosis and Treatment 2
-
- Cancer Genomics and Diagnostics 4
- Breast Cancer Treatment Studies 2
- Co-authors
- Jay Wasman (1 shared paper)Michael T. Tetzlaff (6 shared papers)Alexander J. Lazar (8 shared papers)Stephen Stone (1 shared paper)Michael A. Davies (8 shared papers)Denái R. Milton (3 shared papers)Roland L. Bassett (4 shared papers)Patrick Hwu (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Archives of Pathology & Laboratory Medicine (2 papers)Journal of the American Academy of Dermatology (2 papers)Human Pathology (2 papers)Cancer (1 paper)
- Partner nations
- United StatesIrelandCanada
In The Last Decade
Alan Siroy
18 papers receiving 394 citations
Peers
Comparison fields: 5 of 50
- Dermatology 86
- Oncology 213
- Immunology 70
- Molecular Biology 198
- Pathology and Forensic Medicine 50
Countries citing papers authored by Alan Siroy
This map shows the geographic impact of Alan Siroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Siroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Siroy more than expected).
Fields of papers citing papers by Alan Siroy
This network shows the impact of papers produced by Alan Siroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Siroy. The network helps show where Alan Siroy may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Siroy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 109 | |
| 2 | 2013 | 72 | |
| 3 | 2012 | 45 | |
| 4 | 2006 | 43 | |
| 5 | 2016 | 34 | |
| 6 | 2019 | 24 | |
| 7 | 2011 | 13 | |
| 8 | 2015 | 11 | |
| 9 | 2016 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2015 | 9 | |
| 12 | 2016 | 8 | |
| 13 | 2019 | 8 | |
| 14 | Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma. | 2017 | 6 |
| 15 | 2014 | 3 | |
| 16 | 2015 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2020 | 0 |
About Alan Siroy
Alan Siroy is a scholar working on Oncology, Cancer Research, Dermatology, Rheumatology and Biophysics, having authored 19 papers that have together received 408 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (7 papers), Cancer Genomics and Diagnostics (4 papers), HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Cancer Diagnosis and Treatment (2 papers) and Drug-Induced Adverse Reactions (2 papers). The work is most often cited by research in Dermatology (86 citations), Oncology (213 citations), Immunology (70 citations), Molecular Biology (198 citations) and Pathology and Forensic Medicine (50 citations). Alan Siroy has collaborated with scholars based in United States, Ireland and Canada. Frequent co-authors include Jay Wasman, Michael T. Tetzlaff, Alexander J. Lazar, Stephen Stone, Michael A. Davies, Denái R. Milton, Roland L. Bassett, Patrick Hwu, Jeffrey E. Gershenwald and John D. Miedler. Their work appears in journals such as Journal of Clinical Oncology, Archives of Pathology & Laboratory Medicine, Journal of the American Academy of Dermatology, Human Pathology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.